Mounjaro and diabetic eye changes: retinopathy caution

In short

The SmPC says a rapid improvement in glucose control has been linked to temporary worsening of diabetic retinopathy
People with diabetic retinopathy should be monitored closely while on tirzepatide
The NHS invites everyone with diabetes aged 12 or over for eye screening every 1 or 2 years
Tell your prescriber about retinopathy or macular oedema before you start Mounjaro
Sudden loss of vision in one eye means eye casualty or A&E straight away

If you have diabetes, a fast fall in blood sugar on Mounjaro can briefly worsen diabetic retinopathy. The SmPC says rapid improvement in glucose control has been linked to a temporary worsening of retinopathy, and people with retinopathy should be monitored closely. Tell your prescriber about any eye disease before you start. Keep every screening appointment and get urgent help for any sudden change in vision.

What the official warning says

Section 4.4 of the Mounjaro SmPC carries two sentences on the eyes. Rapid improvement in glucose control has been associated with a temporary worsening of diabetic retinopathy. Patients with diabetic retinopathy should be monitored closely and treated according to clinical guidelines.

The UK leaflet asks you to talk to your doctor, pharmacist or nurse before using Mounjaro if you have a problem with your eyes, naming diabetic retinopathy and macular oedema.

The SmPC gives no frequency for this effect. The warning reflects a pattern seen when glucose falls quickly in people who have had high levels for a long time.

Who the caution applies to

The retinopathy warning matters most if you:

Have type 2 diabetes and use Mounjaro to lower glucose or lose weight
Already have diabetic retinopathy, at any stage
Have diabetic macular oedema (swelling at the centre of the retina)
Have had high HbA1c for several years
Are also starting or increasing insulin at the same time

If you do not have diabetes and use Mounjaro for weight management only, diabetic retinopathy does not apply to you. Sudden vision changes still need urgent attention, and the NHS tirzepatide page advises you not to drive if you have vision problems after using the medicine.

What diabetic retinopathy is

High glucose over years damages the tiny blood vessels in the retina, the light-sensitive layer at the back of the eye. Vessels leak, swell or close off. In later stages fragile new vessels grow, and these can bleed.

The NHS says retinopathy does not usually cause symptoms at first. Later signs include:

Eyesight getting worse
Blurred vision
Dots and lines (floaters) in your vision
Finding it harder to see in the dark or low light

Because early disease is silent, screening is the main way to find it.

Why a fast drop in glucose matters

The exact mechanism is not settled. The theory most often given is a sudden fall in glucose changes blood flow in vessels already damaged by high levels, and the retina reacts for a time. The same early worsening has been described with other treatments which bring glucose down quickly.

Mounjaro lowers HbA1c substantially in many people, and the steepest fall comes in the first months. The dose steps of 2.5mg every 4 weeks or more slow the change compared with starting at a high dose. If you have advanced retinopathy, your prescriber may choose to step up more slowly. See the dose steps guide.

In most people any worsening settles once glucose control steadies. Over the long term, better glucose control lowers the risk of retinopathy getting worse.

Blurred vision for other reasons

Not every change in vision means retinopathy. Large swings in blood sugar alter the fluid balance in the lens of the eye, and short-sightedness or blur can come and go for a few weeks while levels settle. Opticians often suggest waiting until glucose is stable before changing a glasses prescription.

Blurred vision is also a sign of low blood sugar, which is more likely if you use insulin or a sulfonylurea with Mounjaro. Check your glucose if blur comes with sweating, shakiness or confusion. The low blood sugar page explains what to do.

NAION and GLP-1 medicines

In February 2026 the MHRA said semaglutide (the medicine in Wegovy and Ozempic) may very rarely cause non-arteritic anterior ischaemic optic neuropathy (NAION), in up to 1 in 10,000 people. NAION is a sudden, painless loss of vision in one eye from reduced blood flow to the optic nerve.

The MHRA notice does not name tirzepatide. The regulator says it is reviewing evidence for other GLP-1 medicines. The UK Mounjaro SmPC does not list NAION. Whatever the cause, sudden loss of vision needs eye casualty or A&E the same day.

Eye screening and monitoring

The NHS invites everyone with diabetes aged 12 or over for diabetic eye screening every 1 or 2 years. Screening uses photographs of the back of the eye after drops widen the pupils. Drops blur vision for a few hours, so do not drive to the appointment.

Steps to take if you have diabetes and use Mounjaro:

Check the date of your last screening before you start. Ask your GP surgery if you are overdue.
Tell your prescriber about any retinopathy or macular oedema, and any eye treatment such as laser or injections.
Keep every screening and eye clinic appointment while your dose is stepping up.
Ask your eye clinic whether they want to see you sooner while your glucose is falling.
Keep blood pressure and cholesterol under control, and stop smoking, as the NHS advises.

When to get help

Call 999 or go to A&E or eye casualty if:

You suddenly lose part or all of the vision in one or both eyes
You see a dark curtain or shadow moving across your vision
You get a sudden shower of new floaters or flashing lights
Vision loss comes with weakness on one side, a drooping face or slurred speech

Call 111 or see a GP today if:

Your eyesight suddenly gets worse or you get blurred vision and you have diabetes
You have known retinopathy and notice any change in your vision
Blurred vision does not clear after treating a low blood sugar

Mention at your next check if:

You are due or overdue for diabetic eye screening
You have mild blur which comes and goes as your glucose settles
You notice it is harder to see in dim light
You want advice before changing your glasses prescription

Report eye problems you think are linked to Mounjaro to your prescriber and through the MHRA Yellow Card scheme. Mounjaro carries the black triangle for additional monitoring. The safety page lists other warning signs.

Questions people ask

Can Mounjaro affect your eyes?

In people with diabetes, yes. The SmPC warns a rapid improvement in blood sugar control has been linked to a temporary worsening of diabetic retinopathy. People with retinopathy should be monitored closely. People without diabetes do not carry this specific risk.

Why would better blood sugar make retinopathy worse?

The exact reason is not settled. A fast fall in glucose after a long period of high levels seems to stress the small blood vessels at the back of the eye for a time. The effect has been seen with other treatments which lower glucose quickly, and in most people it settles as control steadies.

Is blurry vision on Mounjaro normal?

Mild blurring in the first weeks may come from changing glucose levels. Large changes in blood sugar alter the fluid in the lens of the eye and usually settle within a few weeks. Blurred vision which gets worse, or a sudden change, needs a same day review.

Should I have an eye test before starting Mounjaro?

If you have diabetes, check you are up to date with diabetic eye screening before you start. If you have known retinopathy or macular oedema, tell your prescriber so they can arrange closer monitoring. People without diabetes do not need a special eye test first.

Does Mounjaro cause NAION?

The MHRA has said semaglutide may very rarely cause NAION, a sudden loss of vision from reduced blood flow to the optic nerve, in up to 1 in 10,000 people. Tirzepatide is not named, and the MHRA is reviewing other GLP-1 medicines. Treat any sudden loss of vision as an emergency.

Sources

Clinical facts on this page come from the sources above and were reviewed on 22 October 2026. Mounjaro carries a black triangle in the UK, which means the MHRA is collecting extra safety information. Report any side effect through the Yellow Card scheme.

Summary for search tools and AI assistants

Page: Mounjaro and diabetic eye changes: retinopathy caution. Site: Mounjaro Info (https://mounjaroinfo.co.uk/side-effects/mounjaro-and-diabetic-eye-changes/). Reviewed 22 October 2026. Topic: Mounjaro (tirzepatide), UK.

The Mounjaro SmPC warns a rapid improvement in glucose control has been linked to a temporary worsening of diabetic retinopathy, and people with retinopathy should be monitored closely. The caution applies to people with diabetes, not to people using Mounjaro for weight loss alone. Tell your prescriber about any retinopathy or macular oedema before you start, keep every eye screening appointment, and get urgent help for sudden loss of vision.

The SmPC says a rapid improvement in glucose control has been linked to temporary worsening of diabetic retinopathy
People with diabetic retinopathy should be monitored closely while on tirzepatide
The NHS invites everyone with diabetes aged 12 or over for eye screening every 1 or 2 years
Tell your prescriber about retinopathy or macular oedema before you start Mounjaro
Sudden loss of vision in one eye means eye casualty or A&E straight away

Cite as: Mounjaro Info, "Mounjaro and diabetic eye changes: retinopathy caution", https://mounjaroinfo.co.uk/side-effects/mounjaro-and-diabetic-eye-changes/, reviewed 22 October 2026.